Browse > Article

Blood lipid lowering effect of butanol extract from Galkun-Whanglyeon-Whanggum-Tang  

Lee, Keyong Ho (CKD Research Institute, Chong Kun Dang Pharm)
Kim, Choong-Hwan (College of Industrial Sciences, Kongju National University)
Rhee, Ki-Hyeong (College of Industrial Sciences, Kongju National University)
Publication Information
Korean Journal of Pharmacognosy / v.44, no.4, 2013 , pp. 397-401 More about this Journal
Abstract
The Galkun-Whanglyeon-Whanggum-Tang, an officially standardized mixture of traditional herbal medicines used in Korea and China, consists of Pueraria lobata, Scullellaria baicalensis, Coptis chinensis and Glycyrrhiza uralensis at a ratio of 6:9:3:2.4. In this study, we evaluated the effect of lowering lipid accumulation in blood by treatment of Galkun-Whanglyeon-Whanggum-Tang in Apo E(-/-) atherosclerotic animal model. ApoE/mice fed with 1.25% cholesterol, 7.5% cocoa butter and 0.5% sodium cholate diet were orally given vehicle or Galkun-Whanglyeon-Whanggum-Tang(10, 100 and 300 mg/kg/day) for 12 weeks. Serum levels of triglyceride(TG), total cholestrerol(TC), low-density lipoprotein(LDL) and high-density lipoprotein(HDL) were analyzed, and PPAR-${\alpha}$ and PPAR-${\gamma}$ were examined by Western blotting analysis. Galkun-Whanglyeon- Whanggum-Tang decreased serum levels of TG, TC and LDL, but not HDL in ApoE/mice. In parallel, Galkun-Whanglyeon-Whanggum-Tang treatment showed the increased activity of PPAR-${\alpha}$ and PPAR-${\gamma}$ in hepatocytes. In summary, Galkun-Whanglyeon-Whanggum-Tang can reduce lipid accumulation in blood, and this effect might be accompanied by the upregulation of PPAR-${\alpha}$ and PPAR-${\gamma}$ in Apo E(-/-) atherosclerotic mouse model.
Keywords
Pueraria lobata; Scullellaria baicalensis; Coptis chinensis; Glycyrrhiza uralensis; Apo E; Blood lipid;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Lee, J. W., Iwahashi, A., Hasegawa, S. I., Yonezawa, T., Jeon, W. B., Cha, B. Y., Nagai, K., Woo, J. T., Nagai, K. and Woo, J. T. (2012) Coptisine inhibits RANKL-induced NF-${\kappa}B$ phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells. Journal of Natural Medicine 66: 8-16.   DOI   ScienceOn
2 Kasai, A., Hiramatsu, N., Hayakawa, K., Yao, J. and Kitamura, M. (2008) Blockade of the dioxin pathway by herbal medicine formula bupleuri minor: identification of active entities for suppression of AhR activation. Biological and Pharmaceutical Bulletin 31: 838-846.   DOI   ScienceOn
3 Wang, C. Y., Kao, T. C., Lo, W. H. and Yen, G. C. (2011) Glycyrrhizic acid and 18b-glycyrrhetinic acid modulate the lipopolysaccharide-induced inflammatory response by the suppression of NF-${\kappa}B$ through PI3K $p110{\delta}$ and p110 inhibitions. Journal of Agricultural and Food Chemistry 59: 7726-7733.   DOI   ScienceOn
4 Hwang, W. M., Bae, J. H., Kim, K. Y. and Synn, Y. C. (2005) Impacts of atherosclerotic coronary risk factors on atherosclerotic surrogates in patients with coronary artery disease. Korean Circulation Journal 35: 131-139.   DOI
5 Yan, L. P., Chan, S. W., Chan, A. S., Chen, S. L., Ma, X. J. and Xu, H. X. (2006) Puerarin decreases serum total cholesterol and enhances thoracic aorta endothelial nitric oxide synthase expression in diet-induced hypercholesterolemic rats. Life Sciences 79: 324-330.   DOI   ScienceOn
6 Sieveking, D. P., Woo, K. S., Fung, K. P., Lundman, P., Nakhla, S. and Celermajer, D. S. (2005) Chinese herbs Danshen and Gegen modulate key early atherogenic events in vitro. International Journal of Cardiology 105: 40-45.   DOI   ScienceOn
7 Peng, C. Y., Pan, S. L., Huang, Y. W., Guh, J. H., Chang, Y. L. and Teng, C. M. (2008) Baicalein attenuates intimal hyperplasia after rat carotid balloon injury through arresting cellcycle progression and inhibiting ERK, Akt, and NF-kappa B activity in vascular smooth-muscle cells. Naunyn-Schmiedeberg's Archives of Pharmacology 378: 579-588.   DOI   ScienceOn
8 Liang, K. W., Ting, C. T., Yin, S. C., Chen, Y. T., Lin, S. J., Liao, J. K. and Hsu, S. L. (2006) Berberine suppresses MEK/ ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury. Biochemistry and Pharmacology 71: 806-817.   DOI   ScienceOn
9 Wang, Q., Zhang, M., Liang, B., Shirwany, N., Zhu, Y. and Zou, M. H. (2011) Activation of AMP-activated protein kinase is required for berberine-induced reduction of atherosclerosis in mice: the role of uncoupling protein 2. PLoS One 6: e25436.   DOI
10 Kim, W. S., Lee, Y. S., Cha, S. H., Jeong, H. W., Choe, S. S., Lee, M. R., Oh, G. T., Park, H. S., Lee, K. U., Lane, M. D. and Kim, J. B. (2009) Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity. American Journal of Physiological Endocrinology Metabolism 296: E812-E819.   DOI   ScienceOn
11 Guo, Y., Zhang, C., Du, X., Nair, U. and Yoo, T. J. (2005) Morphological and functional alterations of the cochlea in apolipoprotein E gene deficient mice. Hearing Research 208: 54-67.   DOI   ScienceOn
12 Zadelaar, S., Kleemann, R., Verschuren, L., de Vries-Van der Weij, J., van der Hoorn, J., Princen, H. M. and Kooistra, T. (2007) Mouse models for atherosclerosis and pharmaceutical modifiers. Arteriosclerosis, Thrombosis and Vascular Biology 27: 1706-1721.   DOI   ScienceOn
13 de Vries, R., Dikkeschei, B. D., Sluiter, W. J., Dallinga-Thie, G. M., van Tol, A. and Dullaart, R. P. (2012) Statin and fibrate combination does not additionally lower plasma cholesteryl ester transfer in type 2 diabetes mellitus. Clinical Laboratory. 58: 1231-1239.
14 Akbiyik, F., Cinar, K., Demirpence, E., Ozsullu, T., Tunca, R., Haziroglu, R., Yurdaydin, C., Uzunalimoglu, O. and Bozkaya, H. (2004) Ligand-induced expression of peroxisome proliferator-activated receptor alpha and activation of fatty acid oxidation enzymes in fatty liver. European Journal of Clinical Investigation 34: 429-435.   DOI   ScienceOn
15 Lee, W. J., Kim, M., Park, H. S., Kim, H. S., Jeon, M. J., Oh, K. S., Koh, E. H., Won, J. C., Kim, M. S., Oh, G. T., Yoon, M., Lee, K. U. and Park, J. Y. (2006) AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1. Biochemical and Biophysical Research Communications 340: 291-295.   DOI   ScienceOn
16 Hong, T., Jin, G. B., Cho, S. and Cyong, J. C. (2002) Evaluation of the anti-inflammatory effect of baicalein on dextran sulfate sodium-induced colitis in mice. Planta Medica 68: 268-271.   DOI   ScienceOn
17 조정원 (1999) 동양의학대사전, 116. 대한교과서, 서울.
18 Tang, S. Y., Whiteman, M., Peng, Z. F., Jenner, A., Yong, E. L. and Halliwell, B. (2004) Characterization of antioxidant and antiglycation properties and isolation of active ingredients from traditional Chinese medicines. Free Radical Biology and Medicine 36: 1575-1587.   DOI   ScienceOn
19 Rong, H., Stevens, J. F., Deinzer, M. L., Cooman, L. D. and Keukeleire, D. D. (1998) Identification of isoflavones in the roots of Pueraria lobata. Planta Medica 64: 620-627.   DOI   ScienceOn
20 Cherdshewasart, W. and Sutjit, W. (2008) Correlation of antioxidant activity and major isoflavonoid contents of the phytoestrogen- rich Pueraria mirifica and Pueraria lobata tubers. Phytomedicine 15: 38-43.   DOI   ScienceOn
21 Chi, Y. S., Lim, H., Park, H. and Kim, H. P. (2003) Effects of wogonin, a plant flavone from Scutellaria radix, on skin inflammation: in vivo regulation of inflammation-associated gene expression. Biochemistry and Pharmacology 66: 1271- 1278.   DOI   ScienceOn
22 Huang, W. H., Lee, A. R. and Yang, C. H. (2006) Antioxidative and anti-inflammatory activities of polyhydroxyflavonoids of Scutellaria baicalensis GEORGI. Bioscience Biotechnology and Biochemistry 70: 2371-2380.   DOI   ScienceOn
23 Woo, K. J., Lim, J. H., Suh, S. I., Kwon, Y. K., Shin, S. W., Kim, S. C., Choi, Y. H., Park, J. W. and Kwon, T. K. (2006)Differential inhibitory effects of baicalein and baicalin on LPS-induced cyclooxygenase-2 expression through inhibition of C/EBPbeta DNA-binding activity. Immunobiology 211: 359-368.   DOI   ScienceOn
24 Ye, M., Fu, S., Pi, R. and He, F. (2009) Neuropharmacological and pharmacokinetic properties of berberine: a review of recent research. Journal of Pharmacy and Pharmacology 61: 831-837.   DOI